1. ADC Review. What are antibody-drug conjugates (ADCs)? J Antibody Drug Conjugates. 2019.
https://www.adcreview.com/the-review/antibody-drug-conjugates/what-are-antibody-drug-conjugates/
. Accessed 28 Jun 2019.
2. The Human Protein Atlas. CD79B. 2019.
https://www.proteinatlas.org/ENSG00000007312-CD79B/pathology
. Accessed 28 June 2019.
3. Genentech Inc. Polivy™ (Polatuzumab vedotin-piiq) for injection, for intravenous use: US Prescribing Information. 2019.
https://www.fda.gov
. Accessed 28 June 2019.
4. U.S. Food and Drug Administration. FDA approves polatuzumab vedotin-piiq for diffuse large B-cell lymphoma. 2019.
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-polatuzumab-vedotin-piiq-diffuse-large-b-cell-lymphoma
. Accessed 28 Jun 2019.
5. Seattle Genetics Inc. Seattle Genetics announces antibody-drug conjugate agreement with Genentech [media release]. 22 Apr 2002.
http://www.seattlegenetics.com
.